CME Group, Weatherford International, RPM International And Other Big Stocks Moving Higher On Wednesday

Arrowhead Achieves Clinical Validation for New Drug Platform

Arrowhead Pharmaceuticals reports interim Phase 1/2a data for ARO-DIMER-PA, demonstrating dual-gene silencing to treat high fat in blood.

Arrowhead Pharmaceuticals shares are trading lower. The company announced interim topline data from a Phase 1/2a clinical trial of ARO-DIMER-PA, RNAi therapeutic dimer for the treatment of mixed hyperlipidemia.

10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.

Arrowhead Pharmaceuticals Says Phase 1/2a Interim Single-Dose Data For ARO-DIMER-PA Showed Mean Maximal Reductions Of 54% In Bad Cholesterol, 73% In Triglycerides; No Drug-Related Serious Adverse Events

Shares of crypto-linked stocks are trading higher as Bitcoin prices hit $80,000 amid lower yields and a weaker dollar. Fed's Waller's comments that he is inclined to support holding interest rates steady may have further supported the speculative asset by easing concerns about tighter monetary policy and improving risk appetite.

Cango’s EcoHash Technology Completes Key Operational And Commercial Milestones For Its AI Compute Business

Cango Inc. (NYSE:CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced that its